Nav: Home

Pre-procedure medication regimen could lead to less hospital time for liver cancer patients

June 09, 2016

CINCINNATI -- Researchers at the University of Cincinnati (UC) College of Medicine have found that putting liver cancer patients on a medication regimen prior to undergoing a certain treatment could lead to shorter hospital stays and less chance for readmission due to complications.

These findings are being presented via poster at the World Conference on Interventional Oncology in Boston, June 9-12, 2016.

"Drug Eluting Bead Chemoembolization (DEB TACE) is a minimally invasive procedure performed in interventional radiology to restrict a tumor's blood supply with use of drug-coated beads that deliver chemotherapy locally to the tumor," says Abouelmagd Makramalla, MD, assistant professor of interventional radiology within the UC College of Medicine and a UC Health interventional radiologist who is also the principal investigator on the study. Makramalla is working in collaboration with Ross Ristagno, MD, assistant professor at the UC College of Medicine and interventional radiology section chief.

"A common side effect of this is postembolization syndrome (PES), which could cause fever, nausea and vomiting and pain," Makramalla says. "It usually occurs within the first 72 hours after the procedure and then starts to subside after 72 hours. Standard practice is to hospitalize these patients for one to two days for observation; however, we wanted to see if adding fosaprepitant to the medication regimen, which prevents nausea and vomiting, prior to DEB TACE treatment would allow for the procedure to be outpatient and prevent hospital readmission for PES."

Using a database of patients from UC, researchers reviewed all liver cancer patients who had the DEB TACE procedure over a 23 month period.

Makramalla says the small sample size consisted of 113 consecutive procedures in 71 patients. All patients received premedication with dexamethasone, a steroid, and fosaprepitant, which helps prevent nausea and vomiting caused by chemotherapy. Post-procedural anti-nausea medicines and painkillers were also prescribed as needed. Discharge medications included anti-nausea medications, analgesic medications (painkillers) and an antibiotic.

"Of the 113 DEB TACE procedures, only five patients (4.4 percent), were admitted for PES," he says, adding that 108 treatments (96.4 percent) were successfully performed without development of post-procedure PES that required admission.

"These findings suggest that outpatient DEB TACE could be possible with premedication and a low incidence of hospital readmission for PES; this could allow the patient to recover more comfortably in their home and save both the patient and the hospital time and money. We need larger studies to determine if this could become a standard pre-treatment regimen," he says.

University of Cincinnati Academic Health Center

Related Interventional Radiology Articles:

Radiology organizations publish statement on ethics of AI in Radiology
Experts in the use of artificial intelligence (AI) in radiology, from many of the world's leading radiology, medical physics and imaging informatics groups, today published an aspirational statement to guide the development of AI in radiology.
Society of Interventional Radiology Foundation to bestow annual awards
SIR announces recipients of Leaders in Innovation, young investigator, research and philanthropy awards to be presented during SIR's Annual Scientific Meeting in March.
Society of Interventional Radiology bestows highest honors
The Society of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to Ernest J.
Society of Interventional Radiology Foundation bestows annual awards
Renan Uflacker, M.D., FSIR, was honored posthumously on April 3 with the Society of Interventional Radiology Foundation Leaders in Innovation Award.
Society of Interventional Radiology Foundation bestows annual awards
Society of Interventional Radiology Foundation awards were announced March 4 during the society's Annual Scientific Meeting in Atlanta.
Journal of Vascular and Interventional Radiology, SIR Foundation present awards
The Journal of Vascular and Interventional Radiology (JVIR) -- the Society of Interventional Radiology's peer-reviewed scientific journal - -presented the 2014 JVIR Editor's Best awards during the March 3 general session of the SIR Annual Scientific Meeting, Feb.
Society of Interventional Radiology selects 23 Fellows
Society of Interventional Radiology (SIR) elevated 23 new Fellows during the society's Annual Scientific Meeting, Feb.
Society of Interventional Radiology bestows highest honors
The Society of Interventional Radiology presented its highest honor, the SIR Gold Medal, to Johannes Lammer, M.D., FSIR; Anne C.
Interventional radiology offers new treatment for enlarged prostates
Men with benign prostatic hyperplasia, a condition in which the prostate is enlarged but not cancerous, have a new, breakthrough treatment option.
Interventional radiology treatment relieves chronic plantar fasciitis
Patients suffering from chronic plantar fasciitis now have a new weapon against this debilitating foot ailment.
More Interventional Radiology News and Interventional Radiology Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.